Authors:
Dahmen, N
Muller, MJ
Germeyer, S
Rujescu, D
Anghelescu, I
Hiemke, C
Wetzel, H
Citation: N. Dahmen et al., Genetic polymorphisms of the dopamine D-2 and D-3 receptor and neurolepticdrug effects in schizophrenic patients, SCHIZOPHR R, 49(1-2), 2001, pp. 223-225
Authors:
Muller, MJ
Szegedi, A
Wetzel, H
Benkert, O
Citation: Mj. Muller et al., Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression, SCHIZO BULL, 27(1), 2001, pp. 19-28
Authors:
Anghelescu, I
Germeyer, S
Muller, MJ
Klawe, C
Singer, P
Dahmen, N
Wetzel, H
Himmerich, H
Szegedi, A
Citation: I. Anghelescu et al., No association between the dopamine D-2 receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteria, ALC CLIN EX, 25(6), 2001, pp. 805-809
Authors:
Dahmen, N
Pauly, T
Szegedi, A
Wetzel, H
Anghelescu, I
Ferdinand, K
Hiemke, C
Citation: N. Dahmen et al., Adenylyl cyclase activity is increased in younger, but decreased in older,alcoholic patients after detoxification, ALC ALCOHOL, 35(3), 2000, pp. 249-254
Authors:
Schlosser, R
Wetzel, H
Dorr, H
Rossbach, W
Hiemke, C
Benkert, O
Citation: R. Schlosser et al., Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers, PSYCHONEURO, 25(4), 2000, pp. 377-388
Authors:
Szegedi, A
Lorch, B
Scheurich, A
Ruppe, A
Hautzinger, M
Wetzel, H
Citation: A. Szegedi et al., Cue exposure in alcohol dependent patients: preliminary evidence for different types of cue reactivity, J NEURAL TR, 107(6), 2000, pp. 721-730
Authors:
Muller, MJ
Szegedi, A
Wetzel, H
Benkert, O
Citation: Mj. Muller et al., Moderate and severe depression gradations for the Montgomery-Asberg Depression Rating Scale, J AFFECT D, 60(2), 2000, pp. 137-140
Authors:
Szegedi, A
Muller, MJ
Himmerich, H
Anghelescu, I
Wetzel, H
Citation: A. Szegedi et al., Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients, ALC CLIN EX, 24(4), 2000, pp. 497-500
Authors:
Scheurich, A
Muller, MJ
Wetzel, H
Anghelescu, I
Klawe, C
Ruppe, A
Lorch, B
Himmerich, H
Heidenreich, M
Schmid, G
Hautzinger, M
Szegedi, A
Citation: A. Scheurich et al., Reliability and validity of the German version of the European Addiction Severity Index (EuropASI), J STUD ALC, 61(6), 2000, pp. 916-919
Authors:
Muller, MJ
Rossbach, W
Davids, E
Wetzel, H
Benkert, O
Citation: Mj. Muller et al., Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS), NERVENARZT, 71(3), 2000, pp. 195-204
Authors:
Grunder, G
Muller, MJ
Andreas, J
Heydari, N
Wetzel, H
Schlosser, R
Schlegel, S
Nickel, O
Eissner, D
Benkert, O
Citation: G. Grunder et al., Occupancy of striatal D-2-like dopamine receptors after treatment with thesigma ligand EMD 57445, a putative atypical antipsychotic, PSYCHOPHAR, 146(1), 1999, pp. 81-86
Citation: Mm. Muller et H. Wetzel, IFCC Beckman European Conference 1998 - Frontiers in Molecular Basis of Disease: Inflammatory Diseases, CLIN CH L M, 37(3), 1999, pp. 177-177
Authors:
Szegedi, A
Anghelescu, I
Wiesner, J
Schlegel, S
Weigmann, H
Hartter, S
Hiemke, C
Wetzel, H
Citation: A. Szegedi et al., Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial, PHARMACOPS, 32(4), 1999, pp. 148-153
Authors:
Muller, MJ
Grunder, G
Wetzel, H
Muller-Siecheneder, F
Marx-Dannigkeit, P
Benkert, O
Citation: Mj. Muller et al., Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial, PSYCHIAT R, 89(3), 1999, pp. 275-280
Authors:
Muller, MJ
Marx-Dannigkeit, P
Schlosser, R
Wetzel, H
Addington, D
Benkert, O
Citation: Mj. Muller et al., The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G), J PSYCH RES, 33(5), 1999, pp. 433-443
Authors:
Muller, MJ
Wetzel, H
Szegedi, A
Benkert, O
Citation: Mj. Muller et al., Three dimensions of depression in patients with acute psychotic disorders:A replication study, COMP PSYCHI, 40(6), 1999, pp. 449-457
Authors:
Pauly, T
Dahmen, N
Szegedi, A
Wetzel, H
Bol, GF
Ferdinand, K
Hiemke, C
Citation: T. Pauly et al., Blood ethanol levels and adenylyl cyclase activity in lymphocytes of alcoholic patients, BIOL PSYCHI, 45(4), 1999, pp. 489-493
Authors:
Anghelescu, I
Szegedi, A
Schlegel, S
Weigmann, H
Hiemke, C
Wetzel, H
Citation: I. Anghelescu et al., Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial, EUR NEUROPS, 8(4), 1998, pp. 315-320
Authors:
Szegedi, A
Anghelescu, I
Pauly, T
Dahmen, N
Muller, MJ
Wetzel, H
Hiemke, C
Citation: A. Szegedi et al., Activity of the adenylyl cyclase in lymphocytes of male alcoholic patientsis state dependent, ALC CLIN EX, 22(9), 1998, pp. 2073-2079